Product Code: ANV3181
REPORT HIGHLIGHT
Pharmaceutical Glass Packaging Market size was valued at USD 20,145.2 Million in 2023, expanding at a CAGR of 10.60% from 2024 to 2032.
Pharmaceutical glass packaging plays a critical role in guaranteeing the efficacy, safety, and integrity of pharmaceutical medicines. It entails utilizing specially made glass closures and containers to shield medications from elements, including light, moisture, and chemical reactions that could degrade their quality. Excellent barrier qualities, inertness, and transparency that permit visual examination of the contents are only a few of its many benefits. Glass containers are perfect for keeping and conserving medications since they have a long shelf life and can withstand temperature changes. Glass is also a non-reactive substance that reduces the possibility of contamination or leaching, preserving the stability and purity of pharmaceuticals.
Pharmaceutical Glass Packaging Market- Market Dynamics
Expanding Pharmaceutical Sector to Propel Market Growth
The pharmaceutical sector is expanding quickly, mostly in industrialized nations like the United States, United Kingdom, and Germany, as well as in developing nations like China, India, and Brazil. The pharmaceutical business is expected to experience a boom in demand for glass packaging due to exponential population expansion, increased health awareness, and rising public healthcare system investment. Furthermore, it is anticipated that the pharmaceutical business will use more glass due to growing technological breakthroughs and the adoption of sophisticated manufacturing techniques. Glass has many advantageous qualities, including high recyclability, transparency, and chemical inertness, which will drive up demand for the product in the years to come. Because glass packaging is easily sterilized, it is impervious to moisture and air, which helps the market expand.
Pharmaceutical Glass Packaging Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 10.60% over the forecast period (2024-2032)
Based on product segmentation, the bottles category was predicted to show maximum market share in the year 2023
Based on drug type segmentation, the generic category was the leading type in 2023
On the basis of region, North America was the leading revenue generator in 2023
Pharmaceutical Glass Packaging Market- Segmentation Analysis:
The Global Pharmaceutical Glass Packaging Market is segmented on the basis of Product, Drug Type, and Region.
The market is divided into two categories based on product: Vials & Ampoules, Bottles, Cartridges, and Syringes. The bottles category dominates the market. This segment's growth can be attributed to its superior protective qualities, stiffness, and chemical inertness. Furthermore, bottles are now preferred over other packaging materials for both liquid and solid pharmaceutical preparations, including syrups, pills, capsules, and eye care items. Growth in the market is anticipated to be driven by the pharmaceutical industry's growing need for bottles.
The market is divided into the following categories based on drug type: Generic, Branded, and Biologic. The generic category dominates the market and is likely to maintain its dominance during the forecast period. The aging population, an increase in the number of chronic disease cases, and the increasing number of medicine patents expiring have all contributed to the growth of the generic drug market globally in recent years. Generic medicine consumption is also expected to be boosted by government and healthcare provider initiatives to lower healthcare costs, drug pricing, and the availability of health insurance. The need for pharmaceutical glass packaging is anticipated to rise in response to the growing use of generic medications because of its exceptional barrier properties and regulatory ease.
Pharmaceutical Glass Packaging Market- Geographical Insights
Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.
Over the course of the forecast period, North America is anticipated to hold the greatest share of the global market for pharmaceutical glass packaging. Over the next few years, the pharmaceutical sector is predicted to spend a lot more money in developing markets. It is anticipated that the United States will continue to be the primary catalyst and largest market for the expansion of the pharmaceutical industry in the area, with novel products driving this growth. The rise of generics in the area, which is predicted to experience consistently high demand in terms of volume and sales, is likely to help this growth. Because of the explosive development in the number of consumers and their expenditure, emerging markets are predicted to grow at faster rates than developed ones.
In addition, the pharmaceutical glass packaging market is anticipated to expand at the fastest rate in the world during the projected period in Europe. Europe's pharmaceutical industry, which is centered on research, is a major economic asset. Due to advancements in medical research and development, and the launch of new medications targeted at enhancing the health and standard of living of patients in the area, the pharmaceutical glass packaging business is seeing growth. The national regulations that drive down prices and profits and split the market are expected to play a significant role in differentiating the capabilities of the European research-based pharmaceutical industry from those of its American equivalents.
Pharmaceutical Glass Packaging Market- Competitive Landscape:
Leading players such as Corning Incorporated, Nipro Corporation, SGD S.A., Stoelzle Oberglas GmbH, Bormioli Pharma S.p.A., and others significantly contribute to the market's expansion with their creative solutions, wide range of products, and robust market positioning. These businesses make significant investments in R&D to bring cutting-edge glass packaging solutions that meet the changing demands of the pharmaceutical sector. To provide the best possible protection and preservation of pharmaceutical items, they are constantly improving the barrier qualities, robustness, and design of their glass containers. Additionally, these businesses concentrate on offering a broad range of customization choices, including various sizes, shapes, closures, and labeling options, to satisfy the particular needs of pharmaceutical enterprises.
Recent Developments:
June 2023: At its vial manufacturing facility in Holzminden, Muller & Muller, a producer of main packaging materials made of tubular glass for the pharmaceutical industry, has spent 15 million EUR. Up to 14 new production lines and a matching clean room are part of the investment.
June 2023: In Telangana, India, Corning and SGD Pharma jointly inaugurate a new glass tubing factory and increase access to Corning Velocity Vial technology. Velocity Vials are anticipated to be manufactured at SGD Pharma's plant in Vemula, India, starting in 2024. The production of pharmaceutical tubing is anticipated to start in 2025.
March 2023: To fulfill the growing demand for FIOLAX(R)amber pharma glass in Asia, Schott AG began producing the product in India. Pharmaceutical converters will now be more dependable, well-planned, readily available, and economically efficient thanks to this manufacturer.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Corning Incorporated
Nipro Corporation
Gerresheimer AG
SGD S.A.
Stoelzle Oberglas GmbH
Bormioli Pharma S.p.A.
West Pharmaceutical Services, Inc.
Beatson Clark
Ardagh Group S.A
Schott AG
Arab Pharmaceutical Glass Co.
Piramal Enterprises Ltd.
Sisecam Group
Shandong Medicinal Glass Co., Ltd.
Owens-Illinois, Inc.
DWK Life sciences
Others
GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032
- Vials & Ampoules
- Bottles
- Cartridges
- Syringes
GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET, BY DRUG TYPE- MARKET ANALYSIS, 2019 - 2032
GLOBAL PHARMACEUTICAL GLASS PACKAGING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Pharmaceutical Glass Packaging Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Pharmaceutical Glass Packaging Market Snippet by Product
- 2.1.2. Pharmaceutical Glass Packaging Market Snippet by Drug Type
- 2.1.3. Pharmaceutical Glass Packaging Market Snippet by Country
- 2.1.4. Pharmaceutical Glass Packaging Market Snippet by Region
- 2.2. Competitive Insights
3. Pharmaceutical Glass Packaging Key Market Trends
- 3.1. Pharmaceutical Glass Packaging Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Pharmaceutical Glass Packaging Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Pharmaceutical Glass Packaging Market Opportunities
- 3.4. Pharmaceutical Glass Packaging Market Future Trends
4. Pharmaceutical Glass Packaging Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Pharmaceutical Glass Packaging Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Pharmaceutical Glass Packaging Market Landscape
- 6.1. Pharmaceutical Glass Packaging Market Share Analysis, 2023
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Pharmaceutical Glass Packaging Market - By Product
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2023 & 2032 (%)
- 7.1.2. Vials & Ampoules
- 7.1.3. Bottles
- 7.1.4. Cartridges
- 7.1.5. Syringes
8. Pharmaceutical Glass Packaging Market - By Drug Type
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Drug Type, 2023 & 2032 (%)
- 8.1.2. Generic
- 8.1.3. Branded
- 8.1.4. Biologic
9. Pharmaceutical Glass Packaging Market- By Geography
- 9.1. Introduction
- 9.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
- 9.2. North America
- 9.2.1. Overview
- 9.2.2. Pharmaceutical Glass Packaging Key Manufacturers in North America
- 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.2.5. North America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.2.6. U.S.
- 9.2.6.1. Overview
- 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.2.6.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.2.6.4. U.S. Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.2.7. Canada
- 9.2.7.1. Overview
- 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.2.7.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.2.7.4. Canada Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.3. Europe
- 9.3.1. Overview
- 9.3.2. Pharmaceutical Glass Packaging Key Manufacturers in Europe
- 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.3.5. Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.3.6. Germany
- 9.3.6.1. Overview
- 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.3.6.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.3.6.4. Germany Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.3.7. Italy
- 9.3.7.1. Overview
- 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.3.7.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.3.7.4. Italy Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.3.8. United Kingdom
- 9.3.8.1. Overview
- 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.3.8.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.3.8.4. United Kingdom Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.3.9. France
- 9.3.9.1. Overview
- 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.3.9.4. France Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.3.10. Russia
- 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.3.10.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.3.10.3. Russia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.3.11. Netherlands
- 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.3.11.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.3.11.3. Netherlands Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.3.12. Sweden
- 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.3.12.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.3.12.3. Sweden Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.3.13. Poland
- 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.3.13.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.3.13.3. Poland Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.3.14. Rest of Europe
- 9.3.14.1. Overview
- 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.3.14.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.3.14.4. Rest of the Europe Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.4. Asia Pacific (APAC)
- 9.4.1. Overview
- 9.4.2. Pharmaceutical Glass Packaging Key Manufacturers in Asia Pacific
- 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.4.5. Asia Pacific Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.4.6. India
- 9.4.6.1. Overview
- 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.4.6.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.4.6.4. India Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.4.7. China
- 9.4.7.1. Overview
- 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.4.7.4. China Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.4.8. Japan
- 9.4.8.1. Overview
- 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.4.8.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.4.8.4. Japan Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.4.9. South Korea
- 9.4.9.1. Overview
- 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.4.9.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.4.9.4. South Korea Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.4.10. Australia
- 9.4.10.1. Overview
- 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.4.10.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.4.10.4. Australia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.4.11. Thailand
- 9.4.11.1. Overview
- 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.4.11.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.4.11.4. Thailand Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.4.12. Indonesia
- 9.4.12.1. Overview
- 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.4.12.4. Indonesia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.4.13. Philippines
- 9.4.13.1. Overview
- 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.4.13.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.4.13.4. Philippines Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.4.14. Rest of APAC
- 9.4.14.1. Overview
- 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.4.14.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.4.14.4. Rest of APAC Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.5. Latin America
- 9.5.1. Overview
- 9.5.2. Pharmaceutical Glass Packaging Key Manufacturers in Latin America
- 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.5.5. Latin America Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.5.6. Brazil
- 9.5.6.1. Overview
- 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.5.6.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.5.6.4. Brazil Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.5.7. Mexico
- 9.5.7.1. Overview
- 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.5.7.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.5.7.4. Mexico Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.5.8. Argentina
- 9.5.8.1. Overview
- 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.5.8.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.5.8.4. Argentina Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.5.9. Colombia
- 9.5.9.1. Overview
- 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.5.9.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.5.9.4. Colombia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.5.10. Rest of LATAM
- 9.5.10.1. Overview
- 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.5.10.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.5.10.4. Rest of LATAM Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.6. Middle East and Africa
- 9.6.1. Overview
- 9.6.2. Pharmaceutical Glass Packaging Key Manufacturers in Middle East and Africa
- 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 9.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.6.5. Middle East and Africa Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.6.6. Saudi Arabia
- 9.6.6.1. Overview
- 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.6.6.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.6.6.4. Saudi Arabia Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.6.7. United Arab Emirates
- 9.6.7.1. Overview
- 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.6.7.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.6.7.4. United Arab Emirates Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.6.8. Israel
- 9.6.8.1. Overview
- 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.6.8.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.6.8.4. Israel Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.6.9. Turkey
- 9.6.9.1. Overview
- 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.6.9.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.6.9.4. Turkey Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.6.10. Algeria
- 9.6.10.1. Overview
- 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.6.10.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.6.10.4. Algeria Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.6.11. Egypt
- 9.6.11.1. Overview
- 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.6.11.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.6.11.4. Egypt Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
- 9.6.12. Rest of MEA
- 9.6.12.1. Overview
- 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 9.6.12.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 9.6.12.4. Rest of MEA Market Size and Forecast, By Drug Type, 2019 - 2032 (US$ Million)
10. Key Vendor Analysis- Pharmaceutical Glass Packaging Industry
- 10.1. Competitive Dashboard
- 10.2. Company Profiles
- 10.2.1. Corning Incorporated
- 10.2.2. Nipro Corporation
- 10.2.3. Gerresheimer AG
- 10.2.4. SGD S.A.
- 10.2.5. Stoelzle Oberglas GmbH
- 10.2.6. Bormioli Pharma S.p.A.
- 10.2.7. West Pharmaceutical Services, Inc.
- 10.2.8. Beatson Clark
- 10.2.9. Ardagh Group S.A
- 10.2.10. Schott AG
- 10.2.11. Arab Pharmaceutical Glass Co.
- 10.2.12. Piramal Enterprises Ltd.
- 10.2.13. Sisecam Group
- 10.2.14. Shandong Medicinal Glass Co., Ltd.
- 10.2.15. Owens-Illinois, Inc.
- 10.2.16. DWK Life sciences
- 10.2.17. Others
11. 360 Degree Analyst View
12. Appendix
- 12.1. Research Methodology
- 12.2. References
- 12.3. Abbreviations
- 12.4. Disclaimer
- 12.5. Contact Us